Pharmaceutical Development Services
We hold an MIA (IMP) license for the manufacture, testing and certification of products for use in human clinical trials and we have equipment suitable for provision of IMP’s for Phase I and Phase II studies.
We can manufacture a range of dosage forms including:
Handling poorly water solubles, potents, cytotoxics and controlled drug substances.
Our clinical trial manufacturing services are supported by our analytical and our advanced materials characterisation services.